Press "Enter" to skip to content

Noxopharm releases positive interim results from prostate cancer drug study using radioactive therapy – Small Caps

admin 0

Noxopharm releases positive interim results from prostate cancer drug study using radioactive therapy  Small Caps

Australian biotech drug developer Noxopharm (ASX: NOX) has reported positive interim results from its LUPIN study involving the Veyonda drug developed for …

“prostate cancer” – Google News

(Visited 3 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *